Publications by authors named "Anna B Halpern"

Claim this Profile
P
Predictors of Cardiac Recovery in Adults With AML Who Develop Heart Failure During Treatment.
Matthew Wu, Kathryn Russell, Carole M Shaw, Anna B Halpern, Cristina Ghiuzeli

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular Therapy.
Hannah R Abrams, Helene Starks, Lindsey Bandini, Terry Harrington, Mary-Elizabeth M Percival, Anna B Halpern

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-Hematopoietic Cell Transplantation Ruxolitinib in Transplantation-Eligible Patients with Myelofibrosis: Long-Term Outcomes of a Phase II Prospective Study.
Rachel B Salit, Xinyi Fan, Ted A Gooley, Anna B Halpern, Nellie Ratsamee

Transplant Cell Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm.
Suravi Raychaudhuri, Ted A Gooley, Allegra Rasmussen, Kim Quach, Eva Gill, Anna B Halpern

Blood Neoplasia· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distal gut colonization by oral bacteria during intensive chemotherapy: direct evidence from strain-level analysis of paired samples.
Suravi Raychaudhuri, Hakan Gem, Kevin Chung, Jeffrey S McLean, Kristopher A Kerns, Anna B Halpern

NPJ Biofilms Microbiomes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.
Lucia Masarova, Brandi N Reeves, Firas El Chaer, Lynda Foltz, Tsewang Tashi, Anna B Halpern

Front Med (Lausanne)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of factors predicting low-risk febrile neutropenia admissions in adults with acute myeloid leukemia.
Khushboo V Pal, Megan Othus, Zahra Ali, Katherine Russell, Carole Shaw, Anna B Halpern

Blood Adv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive Reinduction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory High-Grade Myeloid Neoplasms.
Noam E Kopmar, Megan Othus, Kim Quach, Allegra Rasmussen, Kelda Schonhoff, Anna B Halpern

Transplant Cell Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL: A Phase 1 Dose-Escalation Trial.
Noam E Kopmar, Kim Quach, Ted A Gooley, Christen H Martino, Sindhu Cherian, Anna B Halpern

JAMA Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care Patterns and Barriers to Outpatient Care for Adults With AML Following Intensive Chemotherapy at NCCN Member Institutions.
Anna B Halpern, Jessica M Sugalski, Lindsey Bandini, Megan Othus, F Marc Stewart

J Natl Compr Canc Netw· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time independent factors that predict relapse in adults with acute myeloid leukemia.
John J Lim, Megan Othus, Carole M Shaw, Kathryn Russell, Anna B Halpern

Blood Cancer J· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.
Lucas C Zarling, Philip A Stevenson, Lorinda A Soma, Christen H Martino, Mary-Elizabeth M Percival, Anna B Halpern

Eur J Haematol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.
Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasms.
Lauren Shih, Megan Othus, Kelda Schonhoff, Carole Shaw, Jacob Appelbaum, Anna B Halpern

Leukemia· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms.
Julian Lindsay, Carla S Walti, Anna B Halpern, Hu Xie, E Lisa Chung

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents.
Michelle Y Zhang, Megan Othus, Carole Shaw, Kelda G Schonhoff, Anna B Halpern

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a phase I study of continuous infusion cladribine, high-dose cytarabine, and mitoxantrone for relapsed/refractory high-grade myeloid neoplasms.
Noam E Kopmar, Ted Gooley, Niall Curley, Kathryn Russell, Carole Shaw, Anna B Halpern

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia.
Ryan D Cassaday, Lucas C Zarling, Kelsey-Leigh A Garcia, Olga Sala-Torra, Philip A Stevenson, Anna B Halpern

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms.
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung

Leukemia· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasms.
Gabrielle Paras, Megan Othus, Kelda Schonhoff, Carole Shaw, Mohamed Sorror, Anna B Halpern

Leukemia· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive chemotherapy for acute myeloid leukemia relapse after allogeneic hematopoietic cell transplantation.
Elizabeth F Krakow, Roland B Walter, Julia M Nathe, Tess Perez, Ali Ahmed, Anna B Halpern

Am J Hematol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms.
Colin D Godwin, Eduardo Rodríguez-Arbolí, Megan Othus, Anna B Halpern, Jacob S Appelbaum

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physician and patient perceptions on randomization of treatment intensity for unfit adults with acute myeloid leukemia and other high-grade myeloid neoplasm.
Anna B Halpern, Megan Othus, Genevieve Alcorn, Zahra Ali, Kelsey-Leigh A Garcia

Leukemia· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia.
Kelsey-Leigh A Garcia, Sindhu Cherian, Philip A Stevenson, Christen H Martino, Andrei R Shustov, Anna B Halpern

Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes based on treatment setting in refractory acute myeloid leukemia and other high-grade myeloid malignancies.
Noam E Kopmar, Megan Othus, Kelda M Gardner, Carole Shaw, Anna B Halpern

Leukemia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis